504 drugs must pass through bio equivalency tests.

Pursuant to the working rules of Pharmaceutical Affairs Act, the KFDA announced on Dec. 27 that all generic drugs containing the total 504 active ingredients should attach its bio equivalency data at the time of product registration. 504 active ingredients included 273 most frequently prescribing drugs which were within the top 30% in NHI reimbursement volumes and 186 expensive drugs which belo...